Nano-sized carriers in gene therapy for renal fibrosis in vivo

Renal fibrosis is the final common pathway leading to end-stage renal failure regardless of underlying initial nephropathies. No specific therapy has been established for renal fibrosis. Gene therapy is a promising strategy for the treatment of renal fibrosis. Nano-sized carriers including viral vec...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazawa, Haruhisa, Hirai, Keiji, Ookawara, Susumu, Ishibashi, Kenichi, Morishita, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167027/
https://www.ncbi.nlm.nih.gov/pubmed/30410705
http://dx.doi.org/10.1080/20022727.2017.1331099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167027/
https://www.ncbi.nlm.nih.gov/pubmed/30410705
http://dx.doi.org/10.1080/20022727.2017.1331099

Ejemplares similares